19 June 2014

Patients with multidrug-resistant (MDR) tuberculosis could soon have access to a promising new drug - Bedaquiline - as the Medicines Control Council (MCC) is "fast-tracking" its authorisation processes to have the drug licensed... If approved, it will be the first time the drug is widely distributed in this country where more than 10 000 people are diagnosed with MDR - TB every year... The drug, which has already been approved by the Food and Drug Administration in the US, has been undergoing trials in South Africa, via a clinical access programme driven by the national Department of Health. 

Read article below.